The NHS continues to generate more and more data electronically. The drive for more timely, relevant and high quality cancer information increases. Exploiting opportunities to change registration practice has become increasingly important. This session will examine innovations in registration data sources, methods and practice which have been implemented to address these challenges.

Inequalities may take the form of differences in incidence, treatment and outcomes between different groups and can be observed across ages, ethnicities, genders and other distinctions within populations. This session will hear details of recent work to understand the nature and extent of inequalities in cancer in the UK.

Without effective presentation and dissemination the effort spent in collecting and analysing data is wasted. Tools such as eAtlas are simplifying the presentation of data in new and accessible ways. This session invites presentations both of new tools for data presentation and of their use.

This session will address the ways in which multidisciplinary teams (MDTs) can help to improve cancer outcomes through data collection. Invited representatives of MDTs, cancer networks and cancer registries will discuss the role of MDTs in implementing the National Cancer Data Strategy and delivery of the National Cancer Dataset Initiative.

Late presentation is believed to be a factor in the UK's poor cancer survival relative to comparable Western European countries. This session will focus on analyses of patient awareness of cancer and delays in presentation, how data are being used to support early diagnosis, and how linked information can be used to identify and address systematic delays.

This session will provide an international perspective, and invites work comparing cancer care and outcomes in the UK to other countries or examples of work in other countries that would benefit the UK. The session will also include an update on the international benchmarking project being run by the Department of Health.

As the number of people living beyond cancer increases, issues of survivorship are becoming ever more important. This session will present research using data from the NCIN to inform the follow-up and long-term care of cancer survivors, with a particular focus on work to identify possible late effects of treatment.

Novel analyses and data linkages over the past year have provided a wealth of new insights into cancer care in the UK. This session asks what we know now that we didn't a year ago. It will present highlights of work from the NCIN's Site Specific Clinical Reference Groups and from other groups using the NCIN's linked datasets to understand and drive up standards of clinical care.

It has been estimated that up to half of all cancers could be prevented by lifestyle changes, suggesting that the biggest challenge facing NCIN is not the collection of more information but using and communicating what we already know more effectively. This session will address the problems of communicating information on cancer and invites examples of both effective communication and where lessons can be learnt.